Eramet S.a.
ERMAF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1,380 | $1,442 | $1,491 | $1,647 |
| % Growth | -4.3% | -3.3% | -9.5% | – |
| Cost of Goods Sold | $482 | $685 | $534 | $1,564 |
| Gross Profit | $898 | $757 | $957 | $83 |
| % Margin | 65.1% | 52.5% | 64.2% | 5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $805 | -$845 | $845 | $948 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $188 | $1,506 | $157 | -$1,003 |
| Operating Expenses | $993 | $661 | $1,002 | -$55 |
| Operating Income | -$95 | $96 | -$45 | -$49 |
| % Margin | -6.9% | 6.7% | -3% | -3% |
| Other Income/Exp. Net | -$39 | $78 | -$86 | $82 |
| Pre-Tax Income | -$134 | $174 | -$131 | $33 |
| Tax Expense | $45 | $33 | $61 | $73 |
| Net Income | -$152 | $55 | -$41 | $11 |
| % Margin | -11% | 3.8% | -2.7% | 0.7% |
| EPS | -5.31 | 1.93 | -1.44 | 0.39 |
| % Growth | -375.1% | 234% | -469.2% | – |
| EPS Diluted | -5.31 | 1.93 | -1.44 | 0.37 |
| Weighted Avg Shares Out | 29 | 28 | 28 | 28 |
| Weighted Avg Shares Out Dil | 29 | 28 | 28 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $37 | $13 | $58 |
| Interest Expense | $74 | $102 | $86 | $99 |
| Depreciation & Amortization | $115 | $145 | $93 | $125 |
| EBITDA | $21 | $230 | $30 | $177 |
| % Margin | 1.5% | 16% | 2% | 10.7% |